Citations
Showing 10 of 108060 citations.
750 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc fusion protein in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Uboha, Nataliya V. , Chaves, Jorge, Powderly, John D. , Gabrail, Nashat , Zhaohui, Jin, Alistar, Angela , Agensky, Laura, Goel, Apollina, Margossian, Steven, Quayle, Steve, Levisetti, Matteo, Selfridge, Jennifer Eva , Saenger, Yvonne M. , Zheng, Lei , Kim, Dae Won , Alese, Olatunji B. , Fu, Siqing , Gong, Jun , Zhaohui, Jin, Bekaii‐Saab, Tanios
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A846-A846
729 A first-in-human, open-label, multicenter, phase 1/2a, dose escalation and expansion study of GI-102, a novel immunocytokine combining CD80-IL2v3, in patients with advanced or metastatic solid tumors
Lee, Jeeyun , Campian, Jian , Zhao, Yujie , Seetharam, Mahesh , Adjei, Alex A. , Yun, Nari, Lee, Woo-Sun, Lee, Wooyul, Park, Sosun, Seo, Bochan, Lee, Kyungwha, Park, Chong Woo, Cho, Byoung Chul , Lee, Jae‐Lyun , Lee, Jung-Yun , Wee, Wen , Chae, Dongwoo , Jang, Myoung Ho
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A824-A824
636 BASECAMP-1: A master prescreening study to identify patients with high-risk or metastatic solid tumors with HLA loss of heterozygosity (LOH) in preparation for Tmod CAR T-cell therapy trials
Hecht, J. Randolph, Smith, Caleb J. , Welling, Theodore H., Morelli, Maria Pia , Grierson, Patrick , Vu, Peter , Dahiya, Saurabh , Jacobson, Caron A. , Lozac’hmeur, Ariane, Tebbets, Jessica , Ong, Gayanie, Go, William Y., Welch, John S. , Maloney, David G. , Molina, Julian R. , Simeone, Diane M. , Fakih, Marwan , Garon, Edward B. , Kirtane, Kedar , Locke, Frederick L. , Dorigo, Oliver , Park, Jong Chul , Specht, Jennifer M. , Dragovich, Tomislav , Ng, Eric W, Maus, Marcela V
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A727-A728
677 Phase II trial assessing safety, efficacy and immune correlates of heterologous prime-boost with pBI-11 (IM) and TA-HPV (IM) plus pembrolizumab for advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal cancer
Heimann-Nichols, Ellen, Chang, Yung-Nien , Gibson, Michael K. , Savvides, P. , Worden, Francis P. , Wu, T.‐C. , Roden, Richard
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A768-A768
634 EVEREST-1: A seamless phase 1/2 study of CEA logic-gated Tmod CAR T-cell therapy (A2B530) in patients with solid tumors associated with CEA expression also exhibiting HLA loss of heterozygosity (LOH)
Welling, Theodore H., Hecht, J. Randolph , Molina, Julian R. , Smith, Caleb J. , Morelli, Maria Pia , Grierson, Patrick , Patel, Sandip Pravin , Ward, Jeffrey D. , Lozac’hmeur, Ariane, Nikiforow, Sarah , Weng, Wen‐Kai , Vong, Judy, Mardiros, Armen, Liechty, Kirstin B., Go, William Y., Welch, John S. , Maloney, David G. , Punekar, Salman R. , Garon, Edward B. , Fakih, Marwan , Kirtane, Kedar , Lin, Yi , Kopetz, Scott , Locke, Frederick L. , Ward, Jeffrey, Frigault, Matthew J. , Specht, Jennifer M. , Dragovich, Tomislav , Ng, Eric W, Maus, Marcela V , Simeone, Diane M.
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A724-A725
534 Responses to immunotherapy based on programmed death-ligand 1 (PD-L1) copy number variation (CNV) status in patients with advanced non-small cell lung cancer (NSCLC)
Smith, Caleb J. , Parikh, Kaushal , Molina, Julian R. , Leventakos, Konstantinos , Desai, Aakash , Naso, Julia , Ashara, Yash P. , Pitel, Beth A. , Dimou, Anastasios , Mansfield, Aaron S. , Lo, Ying‐Chun
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A608-A609
540 A novel antibody that induces PD-L1 degradation results in enhanced tumor responses in a humanized PD-L1 breast carcinoma mouse model compared to Atezolizumab
Liu, Xin , Harrington, Sue, Lucien-Matteoni, Fabrice, Hsu, Michelle A. , Barham, Whitney , Harrington, Sue, Dong, Haidong
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A614-A614
539 Depletion of soluble PD-L1 with engineered NaNot® nanoparticles promotes antitumor immunity
Hirdler, Jacob, Lavoie, Roxane R. , Orme, Jacob J. , Hawthorne, Lou, Ruegg, Curtis , Dodgson, J, Lucien-Matteoni, Fabrice, Hsu, Michelle A. , Hirdler, Jacob B. , Pavelko, Kevin D. , Liu, Xin , Hawthorne, Lou, Park, Sean S. , Dong, Haidong
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A613-A613
448 Clinical outcomes and safety of immune checkpoint inhibitors (ICI) in patients with solid tumors and paraneoplastic syndromes (PNS)
Zarif, Talal El , Khalid, Ahmed Bilal, Rahme, Serena, Salame, Marita , Am, Edward El, Ahmad, Bachar , Kaldas, David , LeBoeuf, Nicole R. , Malgeri, Andrea , Linnoila, Jenny, McKay, Rana R. , Dilling, Thomas J. , Adib, Elio , Najem, Elie, Sonpavde, Guru , Nassar, Amin H. , Kwak, Lucia , Farhat, Elias Bou , Am, Edward El, Ravishankar, Arjun , Nana, Frank Aboubakar , Naqash, Abdul Rafeh , Sharon, Elad , Cortellini, Alessio , Gupta, Shruti , Sparks, Jeffrey A. , Hamnvik, Ole‐Petter R. , Parikh, Kaushal , Choueiri, Toni K. , Kim, So Yeon
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A498-A498
477 A novel antibody targeting human monocyte-intrinsic PD-L1 promotes immune stimulatory functions of monocytes for antitumor immunity
Li, Ying , Hirdler, Jacob, Lucien-Matteoni, Fabrice, Hsu, Michelle A. , Liu, Xin , Hirdler, Jacob B. , Dong, Haidong
Regular and Young Investigator Award Abstracts | October 31, 2023 | Volume: No volume available | Issue: No issue available | Pages: A536-A536